Alimentary Pharmacology & Therapeutics

The control of gastric acid and Helicobacter pylori eradication
pp. 1383-1401(19)
Authors: Sachs, G.; Shin, J. M.; Munson, K.; Vagin, O.; Lambrecht, N.; Scott, D. R.; Weeks, D. L.; Melchers, K.

Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease
pp. 1403-1409(7)
Authors: Papa, A.; Danese, S.; Gasbarrini, A.; Gasbarrini, G.

Game theory to analyse management options in gastro-oesophageal reflux disease
pp. 1411-1417(7)
Author: Sonnenberg, A.

Budesonide in the treatment of Crohn's disease: a meta-analysis
pp. 1419-1428(10)
Authors: Papi, C.; Luchetti, R.; Gili, L.; Montanti, S.; Koch, M.; Capurso, L.

Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis
pp. 1429-1434(6)
Authors: Green, J. T.; Richardson, C.; Marshall, R. W.; Rhodes, J.; Mckirdy, H. C.; Thomas, G. A. O.; Williams, G. T.

The effect of inflammation severity and of treatment on the production and release of TNFα by colonic explants in inflammatory bowel disease
pp. 1435-1442(8)
Authors: Dionne, S.; Ruemmele, F. M.; Laberge, S.; Seidman, E. G.

Serum transforming growth factor-β1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis
pp. 1443-1449(7)
Authors: Sambuelli, A.; Diez, R. A.; Sugai, E.; Boerr, L.; Negreira, S.; Gil, A.; Camartino, G.; Huernos, S.; Doldán, I.; Felstiner, D.; Bai, J. C.

A randomized controlled trial to assess alendronate-associated injury of the upper gastrointestinal tract
pp. 1451-1457(7)
Authors: Marshall, J. K.; Rainsford, K. D.; James, C.; Hunt, R. H.

Unfavourable effects of colchicine in combination with interferon-α in the treatment of chronic hepatitis C
pp. 1459-1467(9)
Authors: Angelico, M.; Cepparulo, M.; Barlattani, A.; Liuti, A.; Gentile, S.; Hurtova, M.; Ombres, D.; Guarascio, P.; Rocchi, G.; Angelico, F.

Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction
pp. 1469-1477(9)
Authors: Wehrmann, T.; Schmitt, T. H.; Arndt, A.; Lembcke, B.; Caspary, W. F.; Seifert, H.

Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions
pp. 1479-1484(6)
Authors: Bytzer, P.; Hallas, J.

Identifying responders to acid suppression in dyspepsia using a random starting day trial
pp. 1485-1494(10)
Authors: Bytzer, P.; Hansen, J. M.; Rune, S.; Bonnevie, O.; Breinstrup, H.; Funch-Jensen, P.; Matzen, P.; Meineche-Schmidt, V.; Schaffalitzky De Muckadell, O. B.

Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders
pp. 1495-1502(8)
Authors: Sagar, M.; Bertilsson, L.; Stridsberg, M.; Kjellin, A.; Mårdh, S.; Seensalu, R.

The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease
pp. 1503-1509(7)
Authors: Kahrilas, P. J.; Quigley, E. M. M.; Castell, D. O.; Spechler, S. J.

Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol
pp. 1511-1518(8)
Authors: Väkeväinen, S.; Tillonen, J.; Salaspuro, M.; Jousimies-Somer, H.; Nuutinen, H.; Färkkilä, M.

A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine
pp. 1519-1522(4)
Authors: Liu, Wen-Zhong; Xiao, Shu-Dong; Hu, Pin-Jin; Lu, Hong; Cui, Yi; Tytgat, Guido N. J.

High-dose ecabet sodium improves the eradication rate of Helicobacter pylori in dual therapy with lansoprazole and amoxicillin
pp. 1523-1527(5)
Authors: Kagaya, H.; Kato, M.; Komatsu, Y.; Mizushima, T.; Sukegawa, M.; Nishikawa, K.; Hokari, K.; Takeda, H.; Sugiyama, T.; Asaka, M.

Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa
pp. 1529-1535(7)
Authors: Wong, B. C. Y.; Chang, F. Y.; Abid, S.; Abbas, Z.; Lin, B. R.; Van Rensburg, C.; Chen, P. C.; Schneider, H.; Simjee, A. E.; Hamid, S. S.; Seebaran, A; Zhang, J.; Destefano, M.; Lam, S. K.

Safety of proton pump inhibitors
pp. 1537-1538(2)
Authors: Waldum, H. L.; Brenna, E.; Martinsen, T. CHR.